Centiva Capital’s GoodRx Holdings GDRX Stock Holding History

Centiva Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-26,898	Closed	-$119K	–	1741
2025 Q1	$119K	Sell	26,898 -15,360	-36%	-$72.1K	﹤0.01%	1372
2024 Q4	$197K	Sell	42,258 -23,975	-36%	-$132K	﹤0.01%	1372
2024 Q3	$460K	Buy	66,233 +14,287	+28%	+$112K	0.01%	1304
2024 Q2	$405K	Buy	51,946 +22,372	+76%	+$166K	0.01%	1290
2024 Q1	$210K	Buy	29,574 +13,094	+79%	+$86.6K	0.01%	1450
2023 Q4	$110K	Sell	16,480 -25,824	-61%	-$145K	﹤0.01%	1567
2023 Q3	$238K	Buy	42,304 +22,284	+111%	+$149K	0.01%	1305
2023 Q2	$111K	Buy	+20,020	New	+$108K	﹤0.01%	1444

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Centiva Capital's GDRX Position: Q2 2025 in Review

Centiva Capital sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 26,898 shares — an estimated $119K sold.

Centiva Capital first reported a position in GDRX in Q2 2023 and held it in 8 quarters. The position peaked at $460K in Q3 2024. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.

Centiva Capital reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
Centiva Capital sold 26,898 GoodRx Holdings shares in Q2 2025, an estimated $119K.
Centiva Capital first reported a position in GoodRx Holdings in Q2 2023 and held it in 8 quarters.
Centiva Capital's GoodRx Holdings position peaked at $460K in Q3 2024.
182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.